# Erlotinib Versus Radiation Therapy for Brain Metastases in Patients With EGFR-Mutant Lung Adenocarcinoma

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/erlotinib-versus-radiation-therapy-for-brain-metastases-in-patients-with-egfr/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Naamit K. Gerber,Yoshiya Yamada,Andreas Rimner,Weiji Shi,Gregory J. Riely,Kathryn Beal,Helena A. Yu,Timothy A. Chan,Zhigang Zhang,Abraham J. Wu |
| Citations | 96 |
| DOI | 10.1016/j.ijrobp.2014.02.022 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2052185432 |
| PMID | 24679729 |
| Type | article |
| Year | 2014 |

## Paper authors

- [Naamit K. Gerber](https://scholariq.org/researchers/naamit-k-gerber/)

## Paper journal

- [International Journal of Radiation Oncology*Biology*Physics](https://scholariq.org/journals/international-journal-of-radiation-oncology-biology-physics/)

## Paper primary topic

- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

## Paper topics

- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Brain Metastases and Treatment](https://scholariq.org/topics/brain-metastases-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.